Answer
The estimated mean ocular half-life and apparent systemic half-life of faricimab (Vabysmo) are both approximately 7.5 days.
Sources for this answer
- Vabysmo 120 mg/mL solution for injectionRoche Products Limited · emc · SmPC §5.2 Pharmacokinetic properties · Version 8Document updated
Sources checked